Münk Carsten, Brandt Stephanie M, Lucero Ginger, Landau Nathaniel R
The Salk Institute for Biological Studies, Infectious Disease Laboratory, 10010 North Torrey Pines Road, La Jolla, CA 92037.
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13843-8. doi: 10.1073/pnas.212400099. Epub 2002 Oct 4.
Although nonhuman primates are genetically close to humans, their T cells do not support productive replication of HIV-1. In contrast, HIV-1 replicates in activated human CD4(+) T cells, monocytes, and metabolically active human cells of a variety of cell types become permissive for HIV-1 replication when transduced to express CD4 and CCR5 or CXCR4. The molecular basis of this species restriction to HIV-1 replication was investigated by using African green monkey and rhesus macaque cell lines that were stably transduced to express human CD4 and CCR5. The cells supported replication of cognate viruses [simian immunodeficiency virus from African green monkeys (SIV-AGM) and macaques (SIVmac239)] but did not support replication of an R5-tropic cytopathic HIV-1. A beta-lactamase-based HIV-1 entry assay was used to show that the virus efficiently entered the nonhuman primate cells. Provirus formation was reduced 50-fold compared with similarly infected human cells. Real-time PCR quantitation demonstrated that reverse transcription failed to initiate efficiently in the simian cells. The block to reverse transcription was overridden at multiplicity of infection >1 or by preincubation of the nonhuman primate cells with virus, a feature reminiscent of the Friend virus resistance gene-1 (FV-1), restriction to murine leukemia virus replication in mouse cells. Heterokaryon analysis in which human and simian cells were fused demonstrated that the block was dominant. These findings suggested that the primate cells contain a dominant inhibitor that prevents HIV-1 reverse transcription.
虽然非人灵长类动物在基因上与人类接近,但其T细胞不支持HIV-1的有效复制。相比之下,HIV-1在活化的人类CD4(+)T细胞、单核细胞中复制,并且当多种细胞类型的代谢活跃的人类细胞转导表达CD4和CCR5或CXCR4时,它们对HIV-1复制变得易感。通过使用稳定转导以表达人类CD4和CCR5的非洲绿猴和恒河猴细胞系,研究了这种对HIV-1复制的物种限制的分子基础。这些细胞支持同源病毒[来自非洲绿猴的猿猴免疫缺陷病毒(SIV-AGM)和猕猴的(SIVmac239)]的复制,但不支持R5嗜性细胞病变性HIV-1的复制。基于β-内酰胺酶的HIV-1进入试验用于表明该病毒有效地进入了非人灵长类动物细胞。与类似感染的人类细胞相比,前病毒形成减少了50倍。实时PCR定量表明逆转录未能在猿猴细胞中有效地起始。在感染复数>1时或通过用病毒对非人灵长类动物细胞进行预孵育,逆转录的障碍被克服,这一特征让人联想到Friend病毒抗性基因-1(FV-1),它限制小鼠白血病病毒在小鼠细胞中的复制。将人类和猿猴细胞融合的异核体分析表明该障碍是显性的。这些发现表明灵长类动物细胞含有一种显性抑制剂,可阻止HIV-1逆转录。